These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6605364)

  • 1. Viability of Trichomonas vaginalis in vitro at four temperatures.
    Smith RF
    J Clin Microbiol; 1983 Oct; 18(4):834-6. PubMed ID: 6605364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viability of Trichomonas vaginalis in Copan universal transport medium and eSwab transport medium.
    Rivers CA; Schwebke JR
    J Clin Microbiol; 2008 Sep; 46(9):3134-5. PubMed ID: 18614648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viability of Trichomonas vaginalis in urine: epidemiologic and clinical implications.
    Shafir SC; Sorvillo FJ
    J Clin Microbiol; 2006 Oct; 44(10):3787-9. PubMed ID: 16928970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method to increase the viability of Trichomonas vaginalis in urine.
    Shafir SC; Sorvillo FJ; Upcroft JA; Upcroft P
    Sex Transm Dis; 2007 Jul; 34(7):485-7. PubMed ID: 17589330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical note: Preservation of Trichomonas vaginalis viability in urine for laboratorial diagnosis by the wet mount examination.
    da Silva Dias M; Menezes CB; Tasca T
    J Microbiol Methods; 2016 Nov; 130():177-179. PubMed ID: 27666653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The survival of Trichomonas vaginalis at temperatures below +37 degrees C.
    WHITTINGTON MJ
    J Hyg (Lond); 1951 Dec; 49(4):400-9. PubMed ID: 14908048
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens.
    Brown HL; Fuller DA; Davis TE; Schwebke JR; Hillier SL
    J Clin Microbiol; 2001 Sep; 39(9):3197-9. PubMed ID: 11526150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in effect of dog seminal fluid and human seminal fluid and semen on in vitro survival of Trichomonas vaginalis.
    Daly JJ; Sherman JK; Haley T; Hostetler TL
    Sex Transm Dis; 1990; 17(2):106-9. PubMed ID: 2360129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified Field stain - rapid viability test for Trichomonas vaginalis.
    Afzan MY; Sivanandam S; Suresh K
    J Appl Microbiol; 2012 Jan; 112(1):132-7. PubMed ID: 22040369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the heat-shock response of Trichomonas vaginalis.
    Davis SR; Lushbaugh WB
    Am J Trop Med Hyg; 1992 Jul; 47(1):70-7. PubMed ID: 1636886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact-independent cytotoxicity of Trichomonas vaginalis.
    Pindak FF; Mora de Pindak M; Gardner WA
    Genitourin Med; 1993 Feb; 69(1):35-40. PubMed ID: 8444480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the in vitro activity of ceragenins against Trichomonas vaginalis.
    Polat ZA; Cetin A; Savage PB
    Acta Parasitol; 2016 Mar; 61(2):376-81. PubMed ID: 27078662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Trichomonas vaginalis by fungi during associative growth.
    Smith RF; Horen P
    Sex Transm Dis; 1980; 7(4):172-4. PubMed ID: 7006117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth patterns and antigenic analysis of Egyptian Trichomonas vaginalis isolates.
    El-Okbi LM; Arafa M; Salama MS; Abou El-Seoud SM; Mohamad AA; Tawfik RA
    J Egypt Soc Parasitol; 2004 Dec; 34(3):841-55. PubMed ID: 15587311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions.
    Munson E; Napierala M; Basile J; Miller C; Burtch J; Hryciuk JE; Schell RF
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):66-72. PubMed ID: 20727473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Trichomonas vaginalis on modified Columbia agar in the routine laboratory.
    Stary A; Kuchinka-Koch A; Teodorowicz L
    J Clin Microbiol; 2002 Sep; 40(9):3277-80. PubMed ID: 12202565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens.
    Huppert JS; Batteiger BE; Braslins P; Feldman JA; Hobbs MM; Sankey HZ; Sena AC; Wendel KA
    J Clin Microbiol; 2005 Feb; 43(2):684-7. PubMed ID: 15695664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against Trichomonas vaginalis.
    Chang TH; Tsing SY; Tzeng S
    Hybridoma; 1986; 5(1):43-51. PubMed ID: 3514432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
    Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
    Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.